XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 25, 2021
Sep. 26, 2020
Sep. 25, 2021
Sep. 26, 2020
Income Statement [Abstract]        
Net sales $ 539,581 $ 391,566 $ 1,526,863 $ 1,044,999
Cost of sales 325,009 252,735 954,429 681,910
Gross profit 214,572 138,831 572,434 363,089
Selling, general, and administrative expenses 67,468 49,929 199,071 154,328
Research and development expenses 15,779 12,963 46,912 40,587
Amortization of intangibles 10,446 10,104 31,608 29,912
Restructuring, impairment, and other charges 772 1,277 1,998 40,904
Total operating expenses 94,465 74,273 279,589 265,731
Operating income 120,107 64,558 292,845 97,358
Interest expense 4,602 4,988 13,901 16,261
Foreign exchange loss (gain) 3,154 (6,174) 8,315 (9,600)
Other income, net (1,240) (1,682) (10,867) (1,643)
Income before income taxes 113,591 67,426 281,496 92,340
Income taxes 21,537 12,070 49,634 21,331
Net income $ 92,054 $ 55,356 $ 231,862 $ 71,009
Earnings per share:        
Basic (in dollars per share) $ 3.74 $ 2.27 $ 9.43 $ 2.92
Diluted (in dollars per share) $ 3.69 $ 2.25 $ 9.31 $ 2.89
Weighted-average shares and equivalent shares outstanding:        
Basic (in shares) 24,622 24,357 24,582 24,354
Diluted (in shares) 24,926 24,573 24,904 24,535